 | • レポートコード：MRC-IM30317 • 出版社/出版日：IMARC / 2022年11月 • レポート形態：英文、PDF、141ページ • 納品方法：Eメール • 産業分類：化学 |
| Single User | ￥374,850 (USD2,499) | ▷ お問い合わせ |
| Enterprisewide | ￥674,850 (USD4,499) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| グローバル調査会社のIMARC社は、2021年18億ドルであった世界のアプタマー市場規模が2027年には54億ドルに達し、予測期間中、年平均20.4％成長すると予測しています。本調査レポートでは、アプタマーの世界市場を調査・分析し、序論、範囲・調査手法、エグゼクティブサマリー、イントロダクション、種類別（核酸、ペプチド）分析、用途別（診断、治療法、研究・開発、その他）分析、地域別（北米、アジア、欧州、中南米、中東・アフリカ）分析、SWOT分析（強み・弱み・機会・脅威）、バリューチェーン分析、ファイブフォース分析、価格分析、競争状況などの項目を掲載しています。また、こちらの調査レポートに掲載されている企業情報には、Aptagen LLC, Aptamer Group, Aptamer Sciences Inc., Aptus Biotech S.L., Base Pair Biotechnologies Inc., IBA GmbH, Kaneka Eurogentec S.A. (Kaneka Corporation), NeoVentures Biotechnology Inc., NOXXON Pharma, SomaLogic Inc., TriLink BioTechnologies LLC,Vivonics Inc.などが含まれています。 ・序論 ・範囲・調査手法 ・エグゼクティブサマリー ・イントロダクション ・世界のアプタマー市場規模：種類別 - 核酸の市場規模 - ペプチドの市場規模 ・世界のアプタマー市場規模：用途別 - 診断における市場規模 - 治療法における市場規模 - 研究・開発における市場規模 - その他用途における市場規模 ・世界のアプタマー市場規模：地域別 - 北米のアプタマー市場規模 - アジアのアプタマー市場規模 - 欧州のアプタマー市場規模 - 中南米のアプタマー市場規模 - 中東・アフリカのアプタマー市場規模 ・SWOT分析（強み・弱み・機会・脅威） ・バリューチェーン分析 ・ファイブフォース分析 ・価格分析 ・競争状況 |
The global aptamers market size reached US$ 1.8 Billion in 2021. Looking forward, IMARC Group expects the market to reach US$ 5.4 Billion by 2027, exhibiting a growth rate (CAGR) of 20.4% during 2022-2027. Keeping in mind the uncertainties of COVID-19, we are continuously tracking and evaluating the direct as well as the indirect influence of the pandemic. These insights are included in the report as a major market contributor.
Aptamers are versatile oligonucleotides that bind to a specific target, including proteins, peptides, carbohydrates, small molecules, toxins, and live cells. They are modifiable, nonimmunogenic, highly sensitive, less toxic, easy to prepare and have low molecular weight and no variation with different preparations as compared to antibodies. As a result, they are widely being used in therapeutic and biotechnological applications. Besides this, they are also utilized as research agents, diagnostics, biosensors, and tools for biomarker or drug discovery worldwide.
Global Aptamers Market Trends:
The growing prevalence of life-threatening diseases, such as cancer, neurodegenerative, cardiovascular, and acquired immunodeficiency syndrome (AIDS), represents one of the key factors influencing the demand for new and effective detection assays based on aptamer therapy. Moreover, the advent of the chemical modification process to increase the nuclease resistance and enhance the therapeutic properties of aptamers is bolstering the market growth. The aptamers market growth can also be accredited to the rising number of research and development (R&D) activities undertaken for improving diagnostic devices and drugs and their carriers. Apart from this, as aptamers are chemically synthesized, which eliminates batch-to-batch variation and requires less time for development, their application is extensively increasing across the globe. Furthermore, private organizations are collaborating with academic institutes and research laboratories to introduce next-generation products and expand their existing market presence. This is anticipated to fuel the usage of aptamers in a wide range of medical therapies, as well as in the food and beverage (F&B) industry.
Key Market Segmentation:
IMARC Group provides an analysis of the key trends in each sub-segment of the global aptamers market report, along with forecasts at the global, regional and country level from 2022-2027. Our report has categorized the market based on type and application.
Breakup by Type:
Nucleic Acid
Peptide
Breakup by Application:
Diagnostics
Therapeutics
Research and Developments
Others
Breakup by Region:
North America
United States
Canada
Asia-Pacific
China
Japan
India
South Korea
Australia
Indonesia
Others
Europe
Germany
France
United Kingdom
Italy
Spain
Russia
Others
Latin America
Brazil
Mexico
Others
Middle East and Africa
Competitive Landscape:
The competitive landscape of the industry has also been examined along with the profiles of the key players being Aptagen LLC, Aptamer Group, Aptamer Sciences Inc., Aptus Biotech S.L., Base Pair Biotechnologies Inc., IBA GmbH, Kaneka Eurogentec S.A. (Kaneka Corporation), NeoVentures Biotechnology Inc., NOXXON Pharma, SomaLogic Inc., TriLink BioTechnologies LLC and Vivonics Inc.
Key Questions Answered in This Report:
How has the global aptamers market performed so far and how will it perform in the coming years?
What has been the impact of COVID-19 on the global aptamers market?
What are the key regional markets?
What is the breakup of the market based on the type?
What is the breakup of the market based on the application?
What are the various stages in the value chain of the industry?
What are the key driving factors and challenges in the industry?
What is the structure of the global aptamers market and who are the key players?
What is the degree of competition in the industry?
1 Preface
2 Scope and Methodology
2.1 Objectives of the Study
2.2 Stakeholders
2.3 Data Sources
2.3.1 Primary Sources
2.3.2 Secondary Sources
2.4 Market Estimation
2.4.1 Bottom-Up Approach
2.4.2 Top-Down Approach
2.5 Forecasting Methodology
3 Executive Summary
4 Introduction
4.1 Overview
4.2 Key Industry Trends
5 Global Aptamers Market
5.1 Market Overview
5.2 Market Performance
5.3 Impact of COVID-19
5.4 Market Forecast
6 Market Breakup by Type
6.1 Nucleic Acid
6.1.1 Market Trends
6.1.2 Market Forecast
6.2 Peptide
6.2.1 Market Trends
6.2.2 Market Forecast
7 Market Breakup by Application
7.1 Diagnostics
7.1.1 Market Trends
7.1.2 Market Forecast
7.2 Therapeutics
7.2.1 Market Trends
7.2.2 Market Forecast
7.3 Research and Developments
7.3.1 Market Trends
7.3.2 Market Forecast
7.4 Others
7.4.1 Market Trends
7.4.2 Market Forecast
8 Market Breakup by Region
8.1 North America
8.1.1 United States
8.1.1.1 Market Trends
8.1.1.2 Market Forecast
8.1.2 Canada
8.1.2.1 Market Trends
8.1.2.2 Market Forecast
8.2 Asia-Pacific
8.2.1 China
8.2.1.1 Market Trends
8.2.1.2 Market Forecast
8.2.2 Japan
8.2.2.1 Market Trends
8.2.2.2 Market Forecast
8.2.3 India
8.2.3.1 Market Trends
8.2.3.2 Market Forecast
8.2.4 South Korea
8.2.4.1 Market Trends
8.2.4.2 Market Forecast
8.2.5 Australia
8.2.5.1 Market Trends
8.2.5.2 Market Forecast
8.2.6 Indonesia
8.2.6.1 Market Trends
8.2.6.2 Market Forecast
8.2.7 Others
8.2.7.1 Market Trends
8.2.7.2 Market Forecast
8.3 Europe
8.3.1 Germany
8.3.1.1 Market Trends
8.3.1.2 Market Forecast
8.3.2 France
8.3.2.1 Market Trends
8.3.2.2 Market Forecast
8.3.3 United Kingdom
8.3.3.1 Market Trends
8.3.3.2 Market Forecast
8.3.4 Italy
8.3.4.1 Market Trends
8.3.4.2 Market Forecast
8.3.5 Spain
8.3.5.1 Market Trends
8.3.5.2 Market Forecast
8.3.6 Russia
8.3.6.1 Market Trends
8.3.6.2 Market Forecast
8.3.7 Others
8.3.7.1 Market Trends
8.3.7.2 Market Forecast
8.4 Latin America
8.4.1 Brazil
8.4.1.1 Market Trends
8.4.1.2 Market Forecast
8.4.2 Mexico
8.4.2.1 Market Trends
8.4.2.2 Market Forecast
8.4.3 Others
8.4.3.1 Market Trends
8.4.3.2 Market Forecast
8.5 Middle East and Africa
8.5.1 Market Trends
8.5.2 Market Breakup by Country
8.5.3 Market Forecast
9 SWOT Analysis
9.1 Overview
9.2 Strengths
9.3 Weaknesses
9.4 Opportunities
9.5 Threats
10 Value Chain Analysis
11 Porters Five Forces Analysis
11.1 Overview
11.2 Bargaining Power of Buyers
11.3 Bargaining Power of Suppliers
11.4 Degree of Competition
11.5 Threat of New Entrants
11.6 Threat of Substitutes
12 Price Analysis
13 Competitive Landscape
13.1 Market Structure
13.2 Key Players
13.3 Profiles of Key Players
13.3.1 Aptagen LLC
13.3.1.1 Company Overview
13.3.1.2 Product Portfolio
13.3.2 Aptamer Group
13.3.2.1 Company Overview
13.3.2.2 Product Portfolio
13.3.3 Aptamer Sciences Inc.
13.3.3.1 Company Overview
13.3.3.2 Product Portfolio
13.3.4 Aptus Biotech S.L.
13.3.4.1 Company Overview
13.3.4.2 Product Portfolio
13.3.5 Base Pair Biotechnologies Inc.
13.3.5.1 Company Overview
13.3.5.2 Product Portfolio
13.3.6 IBA GmbH
13.3.6.1 Company Overview
13.3.6.2 Product Portfolio
13.3.7 Kaneka Eurogentec S.A. (Kaneka Corporation)
13.3.7.1 Company Overview
13.3.7.2 Product Portfolio
13.3.8 NeoVentures Biotechnology Inc.
13.3.8.1 Company Overview
13.3.8.2 Product Portfolio
13.3.9 NOXXON Pharma
13.3.9.1 Company Overview
13.3.9.2 Product Portfolio
13.3.9.3 Financials
13.3.10 SomaLogic Inc.
13.3.10.1 Company Overview
13.3.10.2 Product Portfolio
13.3.11 TriLink BioTechnologies LLC
13.3.11.1 Company Overview
13.3.11.2 Product Portfolio
13.3.12 Vivonics Inc.
13.3.12.1 Company Overview
13.3.12.2 Product Portfolio
Figure 2: Global: Aptamers Market: Sales Value (in Billion US$), 2016-2021
Figure 3: Global: Aptamers Market Forecast: Sales Value (in Billion US$), 2022-2027
Figure 4: Global: Aptamers Market: Breakup by Type (in %), 2021
Figure 5: Global: Aptamers Market: Breakup by Application (in %), 2021
Figure 6: Global: Aptamers Market: Breakup by Region (in %), 2021
Figure 7: Global: Aptamers (Nucleic Acid) Market: Sales Value (in Million US$), 2016 & 2021
Figure 8: Global: Aptamers (Nucleic Acid) Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 9: Global: Aptamers (Peptide) Market: Sales Value (in Million US$), 2016 & 2021
Figure 10: Global: Aptamers (Peptide) Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 11: Global: Aptamers (Diagnostics) Market: Sales Value (in Million US$), 2016 & 2021
Figure 12: Global: Aptamers (Diagnostics) Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 13: Global: Aptamers (Therapeutics) Market: Sales Value (in Million US$), 2016 & 2021
Figure 14: Global: Aptamers (Therapeutics) Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 15: Global: Aptamers (Research and Developments) Market: Sales Value (in Million US$), 2016 & 2021
Figure 16: Global: Aptamers (Research and Developments) Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 17: Global: Aptamers (Other Applications) Market: Sales Value (in Million US$), 2016 & 2021
Figure 18: Global: Aptamers (Other Applications) Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 19: North America: Aptamers Market: Sales Value (in Million US$), 2016 & 2021
Figure 20: North America: Aptamers Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 21: United States: Aptamers Market: Sales Value (in Million US$), 2016 & 2021
Figure 22: United States: Aptamers Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 23: Canada: Aptamers Market: Sales Value (in Million US$), 2016 & 2021
Figure 24: Canada: Aptamers Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 25: Asia-Pacific: Aptamers Market: Sales Value (in Million US$), 2016 & 2021
Figure 26: Asia-Pacific: Aptamers Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 27: China: Aptamers Market: Sales Value (in Million US$), 2016 & 2021
Figure 28: China: Aptamers Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 29: Japan: Aptamers Market: Sales Value (in Million US$), 2016 & 2021
Figure 30: Japan: Aptamers Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 31: India: Aptamers Market: Sales Value (in Million US$), 2016 & 2021
Figure 32: India: Aptamers Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 33: South Korea: Aptamers Market: Sales Value (in Million US$), 2016 & 2021
Figure 34: South Korea: Aptamers Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 35: Australia: Aptamers Market: Sales Value (in Million US$), 2016 & 2021
Figure 36: Australia: Aptamers Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 37: Indonesia: Aptamers Market: Sales Value (in Million US$), 2016 & 2021
Figure 38: Indonesia: Aptamers Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 39: Others: Aptamers Market: Sales Value (in Million US$), 2016 & 2021
Figure 40: Others: Aptamers Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 41: Europe: Aptamers Market: Sales Value (in Million US$), 2016 & 2021
Figure 42: Europe: Aptamers Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 43: Germany: Aptamers Market: Sales Value (in Million US$), 2016 & 2021
Figure 44: Germany: Aptamers Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 45: France: Aptamers Market: Sales Value (in Million US$), 2016 & 2021
Figure 46: France: Aptamers Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 47: United Kingdom: Aptamers Market: Sales Value (in Million US$), 2016 & 2021
Figure 48: United Kingdom: Aptamers Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 49: Italy: Aptamers Market: Sales Value (in Million US$), 2016 & 2021
Figure 50: Italy: Aptamers Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 51: Spain: Aptamers Market: Sales Value (in Million US$), 2016 & 2021
Figure 52: Spain: Aptamers Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 53: Russia: Aptamers Market: Sales Value (in Million US$), 2016 & 2021
Figure 54: Russia: Aptamers Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 55: Others: Aptamers Market: Sales Value (in Million US$), 2016 & 2021
Figure 56: Others: Aptamers Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 57: Latin America: Aptamers Market: Sales Value (in Million US$), 2016 & 2021
Figure 58: Latin America: Aptamers Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 59: Brazil: Aptamers Market: Sales Value (in Million US$), 2016 & 2021
Figure 60: Brazil: Aptamers Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 61: Mexico: Aptamers Market: Sales Value (in Million US$), 2016 & 2021
Figure 62: Mexico: Aptamers Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 63: Others: Aptamers Market: Sales Value (in Million US$), 2016 & 2021
Figure 64: Others: Aptamers Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 65: Middle East and Africa: Aptamers Market: Sales Value (in Million US$), 2016 & 2021
Figure 66: Middle East and Africa: Aptamers Market: Breakup by Country (in %), 2021
Figure 67: Middle East and Africa: Aptamers Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 68: Global: Aptamers Industry: SWOT Analysis
Figure 69: Global: Aptamers Industry: Value Chain Analysis
Figure 70: Global: Aptamers Industry: Porter's Five Forces Analysis